Shanti Inorganics IPO 2026: Understanding the Business & Key IPO Details
The Indian specialty chemicals sector continues to expand rapidly as manufacturers scale their production lines to meet rising domestic and global demand. Joining the primary market wave, Gujarat-based Shanti Inorganics Limited is launching its initial public offering on the NSE SME platform to raise approximately ₹47.24 crore.
Evaluating a capital-intensive SME chemical company requires the same analytical discipline you apply to comprehensive financial planning. Because this offering demands an upfront minimum retail commitment of over ₹2.65 lakh, prospective bidders must look beyond headline numbers. Investors must evaluate the underlying chemical applications, examine operating margins, and assess how the proposed manufacturing expansion at Bavla will drive future returns. If you are exploring public offerings for the first time, our beginner-friendly guide on what is an IPO provides the necessary foundational knowledge.
In this detailed review of the Shanti Inorganics IPO, we break down the company’s B2B business model, issue dates, valuation metrics, financial statements, core operational strengths, and underlying risks.
Shanti Inorganics IPO: Key Issue Details
Shanti Inorganics aims to raise capital through a book-built public offering. The issue consists predominantly of fresh equity shares, ensuring that the majority of the proceeds flow directly into expanding corporate manufacturing capacity.
| IPO Parameter | Issue Details |
| Company Name | Shanti Inorganics Limited |
| IPO Segment | SME IPO |
| Listing Exchange | NSE SME (Emerge) |
| Issue Type | Book-Built Issue |
| Price Band | ₹79 to ₹83 per equity share |
| Face Value | ₹10 per share |
| Total Issue Size | Up to approx. ₹47.24 crore |
| Fresh Issue | Approx. ₹44.87 crore |
| Minimum Bid Lot | 1,600 shares |
| Minimum Retail Application | 2 Lots (3,200 shares) |
| Minimum Retail Outlay | ₹2,65,600 (at upper price band) |
| Allotment Date | September 3, 2026 |
| Expected Listing Date | September 7, 2026 |
| Registrar | KFin Technologies Limited |
| Lead Manager | Vivro Financial Services Private Limited |
Shanti Inorganics IPO Timeline: Key Dates
Prospective investors should track the official schedule outlined below to ensure timely UPI mandate approvals and application submissions:
| IPO Event | Scheduled Date |
| IPO Opening Date | August 31, 2026 |
| IPO Closing Date | September 2, 2026 |
| Basis of Allotment | September 3, 2026 |
| Initiation of Refunds | September 4, 2026 |
| Credit of Shares to Demat | September 4, 2026 |
| Tentative Listing Date | September 7, 2026 |
If your application does not receive a share allocation during the allotment lottery, review our guide on what happens if you don’t get IPO allotment to understand the automated refund process.
Price Band, Lot Size & Capital Requirements
The issuer has set its IPO price band at ₹79 to ₹83 per equity share with a face value of ₹10. To understand how pricing corridors are formulated in public issues, read our detailed explainer on how IPO share prices are decided in India.
Because Shanti Inorganics is listing on the SME platform, regulatory frameworks enforce higher minimum application thresholds than standard mainboard offerings. Each bid lot contains 1,600 shares. However, this issue mandates that retail individual investors apply for a minimum of two lots (3,200 shares).
Consequently, calculating the minimum retail investment at the upper band of ₹83 yields:
3,200 shares ✕ ₹83 = ₹2,65,600.
Because this public issue locks in an upfront capital outlay of ₹2,65,600, retail market participants must evaluate their liquid cash reserves carefully. Managing substantial capital allocations requires structured budgeting, much like evaluating long-term portfolio growth with a lumpsum calculator or estimating monthly outflows with an EMI calculator.
Shanti Inorganics IPO GMP Trend
As of late August 2026, the reported Grey Market Premium (GMP) for Shanti Inorganics trades around ₹25 across tracking portals.
| Date | Reported GMP | Estimated Listing Price | Potential Listing Gain (%) |
| August 23, 2026 | ₹25 | ₹108 | ~30.12% |
| August 24, 2026 | ₹25 | ₹108 | ~30.12% |
| August 25, 2026 | ₹25 | ₹108 | ~30.12% |
At the upper price band of ₹83, a GMP of ₹25 indicates an estimated listing price of ₹108, signaling an approximate 30.12% premium. However, investors must remember that the grey market reflects unregulated and highly speculative activity. Therefore, fundamental business metrics, operating margins, and balance sheet health should always guide your investment thesis rather than unofficial listing projections.
Business Profile & Operating Model: What Does Shanti Inorganics Do?
Shanti Inorganics Limited operates as a specialized manufacturer and exporter of sulphur-based inorganic chemical compounds. Headquartered in Ahmedabad, Gujarat, the company manufactures technical-grade chemicals that function as critical preservatives, reducing agents, bleaching agents, oxygen scavengers, and process intermediates.
1. The B2B Industrial Operating Model
The company operates strictly on a Business-to-Business (B2B) framework:
Raw Sulphur & Chemical Feedstock → Chemical Processing → Quality Testing→ Industrial Clients Domestic & Export
Shanti Inorganics supplies bulk chemical compounds directly to processing plants, pharmaceutical formulations units, and oilfield service providers who use these inorganic compounds as non-substitutable chemical catalysts and stabilizers.
2. Specialized Product Applications
The company’s product portfolio addresses multiple critical industrial processes:
- Food & Beverages: Sodium metabisulphite serves as an effective antimicrobial preservative and antioxidant in food processing and packaging.
- Oil & Gas Drilling: Ammonium bisulphite and sodium sulphite function as oxygen scavengers in oilfield drilling fluids, preventing catastrophic pipeline corrosion.
- Pharmaceuticals: Specialized bisulphites act as chemical intermediates and reducing agents during active pharmaceutical ingredient (API) synthesis.
- Water Treatment & Pulp/Paper: Inorganic sulphites neutralize residual chlorine, treat industrial wastewater, and assist in paper bleaching operations.
3. International Export Footprint
Beyond its domestic footprint across Indian industrial hubs, Shanti Inorganics exports over 40% of its total output to more than 15 international markets. This geographic reach diversifies its client revenue base and provides exposure to foreign currency realizations.
Offer Objectives: How Will the Company Use the Capital?
The company plans to deploy the net proceeds from the fresh issue predominantly toward establishing a major new production facility:
| Issue Objective | Planned Allocation (₹ Cr) | Primary Strategic Benefit |
| New Bavla Manufacturing Facility | Approx. ₹43.00 Cr | Adds ~78,544 MTPA capacity for Sodium Metabisulphite & Ammonium Bisulphite |
| General Corporate Purposes | Balance Amount | Supports working capital contingencies and public issue expenses |
Directing roughly ₹43 crore toward setting up the new Bavla plant highlights a clear, capacity-driven growth thesis. This substantial expansion will significantly increase output volume to capture expanding export and domestic orders.
Financial Performance Analysis
Shanti Inorganics has delivered steady top-line growth accompanied by consistent margin expansion across the last three financial years.
| Financial Metric | FY2024 | FY2025 | FY2026 | 2M FY2027 (Ending May 2026)* |
| Total Income | ₹45.06 Cr | ₹58.46 Cr | ₹72.93 Cr | ₹16.10 Cr |
| EBITDA | ₹8.72 Cr | ₹12.06 Cr | ₹15.40 Cr | ₹3.50 Cr |
| Profit After Tax (PAT) | ₹5.12 Cr | ₹7.99 Cr | ₹10.22 Cr | ₹2.50 Cr |
| Total Net Worth | ₹17.60 Cr | ₹25.60 Cr | ₹48.24 Cr | ₹50.74 Cr |
| Total Assets | ₹52.69 Cr | ₹66.04 Cr | ₹97.04 Cr | ₹105.12 Cr |
| PAT Margin (%) | 11.36% | 13.68% | 14.01% | 15.53% |
| EBITDA Margin (%) | 19.35% | 20.63% | 21.12% | 21.74% |
(Note: Data for 2M FY2027 covers the unannualized two-month period ending May 31, 2026.)
Consistent Revenue & Profit Scaling
Between FY2024 and FY2026, total income expanded from ₹45.06 crore to ₹72.93 crore, achieving a compound annual growth rate (CAGR) of over 26%. More importantly, Profit After Tax (PAT) doubled from ₹5.12 crore to ₹10.22 crore over the same period. Concurrently, the PAT margin expanded from 11.36% in FY2024 to 14.01% in FY2026, demonstrating strong operational efficiencies and favorable product realizations.
Balanced Debt Profile
The company maintained a moderate Debt-to-Equity ratio of 0.64 in FY2026. Because management funds its Bavla greenfield expansion primarily through IPO equity rather than high-cost bank debt, the balance sheet remains protected against severe interest rate risks.
Valuation & Return Multiples
At the upper price band of ₹83 per share, the Shanti Inorganics IPO reflects attractive fundamental return ratios:
| Valuation Metric | Reported Metric Value |
| Upper Price Band | ₹83.00 |
| Pre-IPO EPS (FY2026) | ₹9.36 |
| Net Asset Value (NAV) per Share | ₹41.74 |
| Debt-to-Equity Ratio | 0.64 |
| Return on Net Worth (RoNW) | 27.68% |
| Return on Capital Employed (ROCE) | 23.40% |
| PAT Margin | 14.01% |
Delivering a 27.68% Return on Net Worth and an ROCE of 23.40% underscores solid capital productivity within the chemical manufacturing space. Evaluating these return metrics helps investors gauge capital efficiency effectively, similar to how disciplined savers track compounding wealth over time using a SIP calculator.
Key Strengths & Potential Investment Risks
Before bidding on the offering, market participants must weigh the company’s operational advantages against its inherent business vulnerabilities.
Key Strengths:
- Diverse End-Use Sectors: Supplying pharmaceuticals, food processing, and oil drilling insulates the company from cyclical downturns in any single industry.
- Major Capacity Expansion: The proposed Bavla facility will add approximately 78,544 MTPA of installed capacity, positioning the firm to handle significantly larger order volumes.
- Healthy Return Profile: Delivering a 27.68% RoNW and consistent double-digit net profit margins reflects pricing power and operational control.
Key Risks:
- Customer Concentration: The top 10 customers accounted for roughly 71.03% of total revenues as of May 2026. The loss of a key client could materially impact revenue.
- Raw Material Price Volatility: Commodity sulphur and chemical feedstocks represent significant input costs; unexpected price spikes could squeeze gross margins.
- Greenfield Project Execution: Deploying ₹43 crore into a new plant carries construction, regulatory clearance, and commissioning risks.
- SME Platform Liquidity: The mandatory two-lot minimum (3,200 shares) creates an entry threshold of ₹2.65 lakh, which can restrict secondary market trading liquidity.
Conclusion
The Shanti Inorganics IPO presents a compelling specialty chemical expansion thesis. The company exhibits steady revenue scaling (26% CAGR), expanding net profit margins (14.01%), and strong return metrics (27.68% RoNW). Furthermore, dedicating ₹43 crore of the fresh issue directly to building the 78,544 MTPA Bavla plant creates a clear pathway for volume-led top-line acceleration.
However, prospective applicants must consider the ₹2.65 lakh minimum retail investment, customer concentration risks, and secondary market liquidity on the NSE SME platform. For investors comfortable with SME equities seeking exposure to a profitable, export-oriented inorganic chemical manufacturer, this issue offers sound fundamental merit. Conversely, conservative investors seeking guaranteed returns may prefer evaluating fixed-income options using an FD calculator rather than exposing large capital blocks to industrial equities.
FAQs
What is the price band and minimum retail investment for the Shanti Inorganics IPO?
The price band is fixed at ₹79 to ₹83 per equity share with a face value of ₹10. Retail investors must apply for a minimum of 2 lots (3,200 shares), requiring an upfront capital outlay of ₹2,65,600 at the upper price band of ₹83.
When does the Shanti Inorganics IPO open and close?
The subscription window opens on August 31, 2026, and closes on September 2, 2026. The registrar will finalize the basis of allotment on September 3, 2026, complete demat credits on September 4, 2026, and list the shares on September 7, 2026.
What is the core business model of Shanti Inorganics?
Shanti Inorganics operates as a B2B manufacturer and exporter of sulphur-based inorganic chemicals (including sodium metabisulphite and ammonium bisulphite) used across food preservation, pharmaceutical synthesis, oilfield drilling, and industrial water treatment.
How will the company utilize the IPO proceeds?
The company will deploy approximately ₹43.00 crore to part-finance the construction of a new 78,544 MTPA manufacturing facility in Bavla, Ahmedabad, while using the remaining balance for general corporate purposes.
What is the current Grey Market Premium (GMP) for the IPO?
As of late August 2026, the reported GMP stands at ₹25, indicating an estimated listing price of roughly ₹108 (approx. 30.12% premium over the issue price).
Disclaimer: Investments in securities are subject to market risks; read all offer documents carefully before investing. This article is strictly for educational purposes and does not constitute financial advice. We are not SEBI-registered advisers. Financial figures, valuations, and Grey Market Premiums (GMP) are based on publicly available data and are subject to change. Always consult a certified financial professional before making investment decisions.
ABOUT THE AUTHOR
